Elevated CRP with Shortness of Breath

What CRP Tells You

"CRP is an acute phase protein made by the liver and released in response to inflammatory cytokines. It is a very sensitive test for inflammation."

Priority Diagnoses (Elevated CRP + Dyspnea)

1. Community-Acquired Pneumonia (CAP) / Infection

• Most common cause of both elevated CRP and dyspnea together
• CRP is markedly elevated in bacterial pneumonia; procalcitonin (PCT) complements CRP for bacterial vs. viral differentiation
• Elevated CRP in nosocomial pneumonia is also a risk factor for mortality, per Murray & Nadel's Textbook of Respiratory Medicine
• Note: CRP/PCT are not sufficiently sensitive or specific alone to distinguish bacterial from viral pneumonia - clinical + radiologic correlation is required (Tintinalli's Emergency Medicine)
• Key workup: Chest X-ray/CT, sputum culture, blood cultures, PCT, CBC with differential

2. Pulmonary Embolism (PE)

• PE causes dyspnea and can mildly-to-moderately elevate CRP from pulmonary infarction and inflammation
• D-dimer is the first-line screening tool (only after appropriate pre-test risk stratification); troponin and BNP for right heart strain
• CRP elevation in PE is secondary, not the primary marker - CT pulmonary angiography (CTPA) confirms

3. COPD Exacerbation

• CRP is an active area of research in COPD. Low CRP may reduce unnecessary antibiotic use; insufficient evidence to use CRP alone to guide antibiotic prescribing in COPD exacerbation (Rosen's Emergency Medicine)
• PCT-guided therapy in critically ill COPD patients was associated with worse 3-month mortality, highlighting limits of biomarker-guided care

4. COVID-19 / Viral Pneumonitis

• Common symptoms: fever, cough, worsening dyspnea, elevated inflammatory markers
• Severe disease: refractory fever, worsening SOB on exertion, altered mental status - CRP substantially elevated (Fuster & Hurst's The Heart, 15th ed.)

5. Acute Pericarditis

• Classic presentation: pleuritic chest pain + dyspnea + elevated CRP
• Elevated high-sensitivity CRP is a risk factor for complicated and recurrent pericarditis
• Therapy targeting inflammation (NSAIDs + colchicine) reduces recurrence (Textbook of Clinical Echocardiography)
• CRP is also used to monitor treatment response - persistent elevation suggests ongoing inflammation

6. Congestive Heart Failure (CHF)

• CHF itself can modestly elevate CRP (chronic inflammation from cytokine release)
• The key differentiating biomarker from lung disease is NT-proBNP/BNP, which is elevated in CHF but not in primary lung disease (Robbins & Kumar Basic Pathology)
• Troponin elevation in CHF is also prognostically relevant

7. Systemic Vasculitis / Connective Tissue Disease

• Diseases like ANCA-associated vasculitis, SLE, or anti-MDA5 dermatomyositis can present with pulmonary involvement (ILD, alveolar hemorrhage) + markedly elevated CRP/ESR
• Scleroderma with ILD: elevated CRP is one of the survival prognosis factors (Rheumatology, Elsevier 2022)
• Consider: ANA, ANCA, anti-MDA5, anti-Scl-70

8. Interstitial Lung Disease (ILD) - Active Exacerbation

• Elevated CRP in RA-associated ILD is a biomarker of disease activity and poor prognosis - a 2024 meta-analysis (PMID 39534599) confirmed CRP among key biomarkers for RA-ILD

9. Sepsis / Systemic Infection

• Very high CRP (often >150-200 mg/L) with dyspnea, fever, hemodynamic changes = sepsis until proven otherwise
• Sources: bacteremia, endocarditis, intra-abdominal infections

10. Malignancy

• Lung cancer, lymphoma, and other malignancies can elevate CRP through paraneoplastic inflammation
• "Extremely elevated CRP" in older literature has been specifically associated with occult malignancy (Tietz Textbook of Laboratory Medicine)

Diagnostic Approach

CRP Magnitude as a Rough Guide

Key Limitation